SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 53.51-1.3%Jan 16 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Brander who wrote (33157)12/14/2009 4:51:12 PM
From: Arthur Radley  Read Replies (1) of 52153
 
Brad,
Concerning the issue of PE, I'm not speaking as the voice of experience on the subject (:>), as I fall more into the Willie Nelson category (:<). (For those that don't get the joke, twas one of Willie's more thought provoking admissions) But it appears that the drug companies are trying to build a market for their drug, when in reality all they are doing is taking two generic drugs and will charge huge amounts to cover their marketing efforts. Couldn't these two ingredient be compounded without any problems?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News